Alternative transcription and alternative splicing in cancer.
about
Potential Gene Interactions in the Cell Cycles of Gametes, Zygotes, Embryonic Stem Cells and the Development of CancerWrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulatorsThe multilayered complexity of ceRNA crosstalk and competitionRNA-seq characterization of spinal cord injury transcriptome in acute/subacute phases: a resource for understanding the pathology at the systems levelTowards improved genome-scale metabolic network reconstructions: unification, transcript specificity and beyondELF5 isoform expression is tissue-specific and significantly altered in cancer.NPEBseq: nonparametric empirical bayesian-based procedure for differential expression analysis of RNA-seq dataValidation of predicted mRNA splicing mutations using high-throughput transcriptome data.Next Generation Sequencing Data and Proteogenomics.Chromatin states reveal functional associations for globally defined transcription start sites in four human cell lines.Identification of TMEM208 and PQLC2 as reference genes for normalizing mRNA expression in colorectal cancer treated with aspirin.Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseasesThe role of mRNA splicing in prostate cancer.Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype.Identification and characterization of alternative exon usage linked glioblastoma multiforme survivalAlternative RNA structure-coupled gene regulations in tumorigenesis.A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer.Mechanism of alternative splicing and its regulationThe Associations between RNA Splicing Complex Gene SF3A1 Polymorphisms and Colorectal Cancer Risk in a Chinese Population.A convex formulation for joint RNA isoform detection and quantification from multiple RNA-seq samples.A serine-arginine-rich (SR) splicing factor modulates alternative splicing of over a thousand genes in Toxoplasma gondii.Long genes and genes with multiple splice variants are enriched in pathways linked to cancer and other multigenic diseases.Functional divergence and convergence between the transcript network and gene network in lung adenocarcinoma.Alternative Splicing in Adhesion- and Motility-Related Genes in Breast CancerTriple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levelsAn 80-gene set to predict response to preoperative chemoradiotherapy for rectal cancer by principle component analysismRNA splicing variants: exploiting modularity to outwit cancer therapyIsoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes.Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia.Alternative splicing programs in prostate cancer.Protein moonlighting: a new factor in biology and medicine.Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives.Identification of a novel gene fusion (BMX-ARHGAP) in gastric cardia adenocarcinomaIntegrative gene set enrichment analysis utilizing isoform-specific expression.The CRISPR/Cas system inhibited the pro-oncogenic effects of alternatively spliced fibronectin extra domain A via editing the genome in salivary adenoid cystic carcinoma cells.Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer.An integrative framework identifies alternative splicing events in colorectal cancer development.Genomic variants link to hepatitis C racial disparities.hMENA splicing program impacts the clinical outcome of early stage lung cancer patients. How and why?Identification of a second PAD1 in Brettanomyces bruxellensis LAMAP2480.
P2860
Q26781101-13891D87-7FC1-41A0-BD17-59EB2A5572A1Q27000495-F5BC463C-0671-480A-A3C9-5A80869C1FB3Q27025671-ADB6C253-2B7A-4F42-8A45-3DC78A05DCF3Q28535228-15E9E84B-873F-4780-AFF8-A161B8CCA657Q28817802-A6352C28-43CF-4B8C-824F-7F18F7EFD7DBQ30383247-F9439D42-B77B-4011-9A2E-82E3313CC149Q30663634-568F221E-FEE4-4565-9948-189B7C8C98D0Q30802918-48AD3471-8F6D-4151-A474-27B4EED8E839Q31133823-490A0CE2-C307-4EB8-8033-483D30794C77Q31154613-B84BFE26-F224-413F-9CA6-FFD6412DC4C1Q33618460-8CD6A831-E82F-4798-BE0A-EC0658416913Q33909288-B064C04C-5ABB-4E3F-9025-BCBF20E1391EQ33922376-FC9E3F01-6988-4AE2-850E-2C3D90E7A3ADQ34017091-CF5D9A2A-4838-4EA3-935C-363CB6F87B69Q34498701-237A7524-C807-435B-8466-D512B7B99323Q35016456-A01763E1-CF1F-4BF8-9EA4-AF7FD483310CQ35091466-5A20CC53-4F9A-4EA1-84A9-1CCBA5A34791Q35179872-2D202846-6367-4064-9E0A-F97FECBC7AEBQ35664934-90F87BA1-1713-4CD7-807A-5F23472B98D4Q35749763-0FD57E02-AA8E-4316-99B5-87F0D4D83285Q35786106-B6CEF652-BA59-4BD3-90B2-1220AB226DBFQ35954511-02616473-A068-4B0E-B5BA-069B849C603CQ36473639-FF5BF2FF-8872-430B-A87F-525CF26DEFDEQ36512674-A3C0A8E5-969B-41BD-9BC3-618DCF5846DFQ36557126-786C1F42-0BAF-4E45-9FBD-01E493BAA9BCQ36824711-A4395EF8-8E25-4485-B483-7003C4EF339BQ37154455-BD1050AF-37BF-4AA8-8A4C-89EA4DD02471Q37734374-2FFB4640-F958-4085-98B0-CFA736ACC576Q38074757-98E8DC7D-E6F7-491A-A62F-99734A653676Q38132132-8F489E02-AB25-4189-9722-7B93917CDE73Q38268466-3E8C4581-6735-4515-BDDE-FDD024BE575BQ38325485-D7729913-EB90-4937-87C9-5F842BCCA6ECQ38469149-6BD37815-D836-4E67-A257-B7C90AB8B621Q38744262-9A0F0C76-6A7D-43EA-9D68-5540AB20D218Q38909254-AC178533-7A8B-4EEA-93F7-37CA672280D5Q40421665-68CDC65B-27D1-4C5E-A385-26E8B4907275Q41134777-1C4C83D7-27D6-44EB-9DD2-6A5ED189EB91Q41708713-7917F762-7EC2-41E2-9EE1-DEDFB0239211Q45904310-65B3F402-0738-481D-A13F-6C119911CD1FQ46472709-512A7C79-DF59-4847-941C-43D35755B0BC
P2860
Alternative transcription and alternative splicing in cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Alternative transcription and alternative splicing in cancer.
@en
type
label
Alternative transcription and alternative splicing in cancer.
@en
prefLabel
Alternative transcription and alternative splicing in cancer.
@en
P2093
P1476
Alternative transcription and alternative splicing in cancer.
@en
P2093
Ramana V Davuluri
Ravi Gupta
Sharmistha Pal
P304
P356
10.1016/J.PHARMTHERA.2012.08.005
P577
2012-08-14T00:00:00Z